FDA 483 - Zhejiang Bamboo Pharmaceuticals Co., Ltd. - September 27, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Zhejiang Bamboo Pharmaceuticals Co., Ltd. in Shangyu District, China, was cited for significant deficiencies in its quality control and equipment cleaning practices. The firm failed to adequately investigate out-of-specification results and production deviations, lacking complete documentation and comprehensive root cause analysis. Additionally, equipment used in API and intermediate production was not properly cleaned or stored, leading to potential contamination and product quality issues.
ID · 000fe5f7-844d-4a99-b1a9-b0d9bc1a3f57